Fundraising FoxAllerotherapeutics
1 known investors
Find your way into Allerotherapeutics
381 people in our graph can introduce you to the Allerotherapeutics team.
Sign up to see every warm intro you have to Allerotherapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Allerotherapeutics team. We find them
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Allero Therapeutics is a biotech company focused on immunotherapy solutions for allergy and immune-mediated disorders, particularly Celiac Disease. The company is led by experienced pharmaceutical and biotech executives with deep expertise in immunotherapy R&D and allergen management.
Founders & leadership
EP
Emil PotCEO
FG
Federico GregoCFO
PS
Poul SørensenCSOPoul Sørensen holds a PhD in Biochemistry from Copenhagen University and serves as Chief Scientific Officer at Allerotherapeutics, a biotech company developing immunotherapy solutions for allergy and immune-mediated disorders. He has founded multiple biotech ventures and held leadership roles in R&D, strategy, and business development with focus on inflammation and immunology.
Investors · 1
Frequently asked questions
- What does Allerotherapeutics do?
- Allero Therapeutics is a biotech company focused on immunotherapy solutions for allergy and immune-mediated disorders, particularly Celiac Disease. The company is led by experienced pharmaceutical and biotech executives with deep expertise in immunotherapy R&D and allergen management.
- Who are Allerotherapeutics's investors?
- Allerotherapeutics's investors include Curie Capital.